Showing results (121-130 of 162) with videos related to

Sort By:
Pageof 17
Transplantation and Cellular Therapy|November 30, 2025
Outcomes of Terminal Complement Blockade in Adults with High-Risk Transplant-Associated Thrombotic Microangiopathy: A Comparative AnalysisMohammad Alhomoud, Glenn Heller, Christina Cho, et al.
Blood Advances|August 19, 2024
Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicityBrian C Shaffer, Samantha Brown, Stephanie Chinapen, et al.
Blood Advances|July 14, 2026
Infection Burden in Mismatched Unrelated Donor Hematopoietic Cell Transplantation: Results from the ACCESS TrialJeffery J Auletta, Joseph Stanek, Stephanie Bo-Subait, et al.
Blood Advances|April 26, 2024
High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease preventionNoa G Holtzman, Lauren M Curtis, Rachel B Salit, et al.
Transplantation and Cellular Therapy|October 3, 2025
Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic TransplantationShannon R McCurdy, Scott R Solomon, Brian C Shaffer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 28, 2017
Impact of Toxicity on Survival for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell TransplantationGunjan L Shah, Michael Scordo, Satyajit Kosuri, et al.
Blood Advances|October 6, 2025
Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamideDipenkumar Modi, Yosra M Aljawai, Todd E DeFor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2024
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated DonorsBrian C Shaffer, Mahasweta Gooptu, Todd E DeFor, et al.
American Journal of Hematology|September 9, 2023
Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemiaKarthik Nath, Jasme Lee, Theresa A Elko, et al.
Brain, Behavior, and Immunity|April 27, 2020
Baseline immunoreactivity before pregnancy and poly(I:C) dose combine to dictate susceptibility and resilience of offspring to maternal immune activationMyka L Estes, Kathryn Prendergast, Jeremy A MacMahon, et al.
Pageof 17